Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model

समान संसाधन

• Exposure–response analysis of adverse events associated with molibresib and its active metabolites in patients with solid tumors
  द्वारा: Anu Shilpa Krishnatry, और अन्य
  प्रकाशित: (2022-05-01)
• A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
  द्वारा: Smythe, Wynand, और अन्य
  प्रकाशित: (2012)
• A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114
  द्वारा: Hikari Araki, और अन्य
  प्रकाशित: (2022-05-01)
• An Adaptive Physiologically Based Pharmacokinetic–Driven Design to Investigate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Molibresib (GSK525762) in Healthy Female Volunteers
  द्वारा: Riddell, Kylie, और अन्य
  प्रकाशित: (2020)
• Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites.
  द्वारा: Kudriakova, T B, और अन्य
  प्रकाशित: (1992)